Aryl-substituted acetamide and pyrrolidin-2-one derivatives and their use for the treatment of seizures
Aryl-substituted acetamide and pyrrolidin-2-one (γ-butyrolactam) derivatives have useful activity in the inhibition, prevention, or treatment of seizures. The derivatives may be useful in the treatment of epilepsy, including medically refractory epilepsy, and nerve agent poisoning..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Europäisches Patentamt - (2023) vom: 07. Nov. Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
DUBROVSKIY ANTON [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-11-07, Last update posted on www.tib.eu: 2024-01-18, Last updated: 2024-01-26 |
---|
Patentnummer: |
US11806333 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA018591620 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA018591620 | ||
003 | DE-627 | ||
005 | 20240126103641.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231201s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA018591620 | ||
035 | |a (EPA)US11806333 | ||
035 | |a (EPA)64664447 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a DUBROVSKIY ANTON |e verfasserin |4 aut | |
245 | 1 | 0 | |a Aryl-substituted acetamide and pyrrolidin-2-one derivatives and their use for the treatment of seizures |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2023-11-07, Last update posted on www.tib.eu: 2024-01-18, Last updated: 2024-01-26 | ||
520 | |a Aryl-substituted acetamide and pyrrolidin-2-one (γ-butyrolactam) derivatives have useful activity in the inhibition, prevention, or treatment of seizures. The derivatives may be useful in the treatment of epilepsy, including medically refractory epilepsy, and nerve agent poisoning. | ||
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a KRIVOSHEIN ARCADIUS V |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 07. Nov. |
773 | 1 | 8 | |g year:2023 |g day:07 |g month:11 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/64664447/publication/US11806333A1?q=US11806333 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
936 | u | w | |j 2023 |b 07 |c 11 |
951 | |a AR | ||
952 | |j 2023 |b 07 |c 11 |